What does Epimède invest in?
Epimède invests most often at Series B (100% of the rounds on record).
Epimède highlights
- 01
1 rounds on record
- 02
Mostly Series B: 100% of its rounds
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2019
1 round
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
4 of 11 we have independently watched raise
EndotoolsImcyseNcardiaNovadipAsitbiotechEthiasGwmaLaseaMantagraphicRadiomicsWishbone-biotech
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.